Anika Therapeutics GAAP EPS of -$0.02 misses by $0.08, revenue of $30.59M beats by $1.15M

Anika Therapeutics Q3 results: EPS missed, but revenue beat estimates and rose 10% year over year.

CryptoAlerta — análise de criptomoedas e mercado em tempo real